Clinical News

New Phase I study shows up to 6,000mg of CBD relatively well tolerated in healthy participants

Published by External Author,
30, Oct

A new study has found that 6,000mg of CBD is relatively well tolerated in healthy participants.

Research into the impacts of CDB on the body

A phase I study released in October this year sought to asses the safety, tolerability and PK of CBD oral solution in healthy adult volunteers, as well as the effect of food on CBD PK parameters. The results showed encouraging signs that CDB was tolerated.

To read the full study click here

You might also be interested in


Cannabis helping those with chronic pain

Published by External Author.

24 Oct


Cannabis oil could be used to treat insomnia after Perth trial

Published by External Author.

26 May


Asia plants seeds for medical cannabis market

Published by External Author.

04 Nov

View all articles